IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

August 27-28, 2018

Cambridge Healthtech Institute’s 3rd Annual Oncolytic Virus Immunotherapy: Commercializing the Exciting Potential of Oncolytic Virotherapy

Stephen J. Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer
Presentation: “Progress with Oncolytic Vesicular Stomatitis Viruses”

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com